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Abstract
Coeliac disease (CD, sometimes called gluten-sensitive enteropathy or nontropical sprue) is an inflammatory disorder of the small intestine 
of autoimmune origin. It occurs in genetically predisposed people and is induced by a gluten protein, which is a component of wheat. 
The prevalence of histologically confirmed CD is estimated in screening studies of adults in the United States and Europe to be between 
0.2% and 1.0%. The results of previous studies have indicated that the prevalence of CD is increased in patients with other autoimmune 
disorders such as: autoimmune thyroid diseases, type 1 diabetes mellitus, and Addison’s disease. A coincidence of the above diseases 
constitutes autoimmune polyglandular syndrome (APS). The high prevalence of CD in APS is probably due to the common genetic 
predisposition to the coexistent autoimmune diseases. The majority of adult patients have the atypical or silent type of the disease. This 
is the main reason why CD so often goes undiagnosed or the diagnosis is delayed. CD, if undiagnosed and untreated, is associated with 
many medical disorders including haematological (anaemia), metabolical (osteopenia/osteoporosis), obstetric-gynaecological (infertil-
ity, spontaneous abortions, late puberty, early menopause), neurological (migraine, ataxia, epilepsy) as well as with an increased risk of 
malignancy, especially: enteropathy-associated T-cell lymphoma, small intestine adenocarcinoma, and oesophageal and oropharyngeal 
carcinomas. Early introduction of a gluten-free diet and lifelong adherence to this treatment decreases the risk of these complications. (Pol 
J Endocrinol 2012; 63 (3): 240–249)
Key words: coeliac disease, autoimmune polyglandular syndrome, Graves’ disease, autoimmune thyroid disease, type 1 diabetes, autoimmune 
adrenal insufficiency
Streszczenie
Celiakia (inaczej: glutenozależna choroba trzewna, enteropatia glutenowrażliwa, sprue nietropikalna) jest enteropatią zapalną jelita cienkiego 
o podłożu autoimmunologicznym, spowodowaną trwałą nietolerancją glutenu zawartego w zbożach, występującą u osób z predyspozycją 
genetyczną. Częstość potwierdzonej histopatologicznie celiakii w ogólnej populacji dorosłych, według wyników badań przesiewowych 
przeprowadzonych w Europie oraz Stanach Zjednoczonych, wynosi 0,2–1,0%. Wyniki dotychczasowych badań sugerują, że ryzyko zachoro-
wania na celiakię jest kilkakrotnie większe u pacjentów z innymi chorobami autoimmunologicznymi, jak np.: choroby autoimmunologiczne 
tarczycy (AITD), cukrzyca typu 1 (T1D) czy choroba Addisona. Powyższe choroby wchodzą w skład autoimmunologicznych zespołów 
niedoczynności wielogruczołowej (APS). Jedną z przyczyn większej częstości występowania celiakii w APS, w porównaniu z ogólną popu-
lacją, jest prawdopodobnie wspólna predyspozycja genetyczna. U osób dorosłych zdecydowaną większość przypadków stanowią postacie 
atypowe i nieme. Wpływa to na opóźnioną i obniżoną wykrywalność choroby. Nierozpoznana i nieleczona celiakia może prowadzić do 
wielu zaburzeń, w tym m.in.: hematologicznych (niedokrwistość), metabolicznych (osteopenia/osteoporoza), ginekologiczno-położniczych 
(niepłodność, wzrost częstości samoistnych poronień, opóźnione dojrzewanie i wcześniejsza menopauza) i neurologicznych (migrena, 
ataksja, padaczka). Nieleczona celiakia zwiększa również ogólne ryzyko zachorowania na złośliwe nowotwory, w tym przede wszystkim 
na: chłoniaka jelita cienkiego, gruczolakoraka jelita cienkiego, gardła i przełyku. Skuteczne leczenie (dieta bezglutenowa), wprowadzone 
wcześnie i kontynuowane przez całe życie, zmniejsza ryzyko wystąpienia wymienionych powikłań. (Endokrynol Pol 2012; 63 (3): 240–249)
Słowa kluczowe: choroba trzewna, autoimmunologiczny zespół niedoczynności wielogruczołowej, choroba Gravesa i Basedowa, 
autoimmunologiczna choroba tarczycy, cukrzyca typu 1, autoimmunologiczna niedoczynność nadnerczy
Case report
A 22 year-old female was admitted to the clinic for her 
regular check-up. She had been diagnosed with Graves’ 
disease (GD) at the age of 15. She was treated with an-
tithyroid drugs from the age of 15 to the age of 20 and 
twice underwent treatment with radioiodine (at the 
age of 20). Before admission to hospital, she had been 
taking 150 µg of levothyroxine. She was suffering from 
recurrent constipation and moderate abdominal pain. 
Additionally, she complained of a feeling of enamel 
oversensitivity and severe migraines, which required 
treatment with non-steroidal anti-inflammatory 
drugs. For several years, the patient was diagnosed 
with an iron deficiency and administered iron orally. 
She denied having heavy menorrhagia. She pointed out 
that the presence of autoimmune disorders ran in her 
family (her father suffered from GD as well). Laboratory 
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tests showed a normal TSH serum level (1.07 uIU/mL, 
N: 0.2–4.0) a low ferritin level (6 ng/mL, N: 13–150), 
a low iron level (36 ug/ml, N: 37–181), normal serum 
Hb, folic acid, vitamin B12, calcium, phosphorus, total 
proteins and albumin levels. Specific serological stud-
ies were performed revealing high levels of IgA tissue 
transglutaminase antibodies (IgA TTG) (178.1 U/mL; 
N: < 20.0) and IgA endomysial antibodies (IgA EMA) 
(54.5 U/mL; N: < 20.0). An endoscopy of the upper di-
gestive tract was performed and a biopsy was obtained 
from the descending part of the duodenum. Duodenal 
mucosa showed atrophic changes with loss of folds 
and contained visible fissures. Microscopic examina-
tion showed an increase in intraepithelial lymphocytes, 
crypt hyperplasia and villous atrophy — Type III in 
Marsh classification (Tab. I, Fig. 1). Coeliac disease (CD) 
was diagnosed and a gluten-free diet was introduced. 
The patient was invited for a check-up three months 
after the introduction of a gluten-free diet, and neither 
symptoms of digestive system disorders, nor migraines 
and enamel oversensitivity were present. However, it 
was observed that serum iron and ferritin concentra-
tions remained low. During following check-ups, the 
dose of levothyroxine was gradually lowered to 125 µg, 
with a normal serum TSH level. Iron supplements were 
stopped and gradually blood iron and ferritin levels 
stabilised. The patient regularly visits an endocrinologist 
and a gastroenterologist.
Introduction
Coeliac disease (CD), also known as gluten-sensitive 
enteropathy and nontropical sprue,, is a small bowel 
disorder characterised by mucosal inflammation of 
autoimmune origin caused by persistent intolerance to 
gluten, a protein which is a component of cereal (rye, 
wheat, barley). CD occurs in people with a genetic pre-
disposition [1]. The symptoms of CD were first described 
by Dr. Samuel Gee in 1888, but the aetiology of the 
symptoms remained unclear for many years [2]. In the 
1940s, a paediatrician from Denmark, Wiliam K. Dicke, 
recognised the association between diets which con-
tained gluten and the symptoms of CD [3]. In periods 
of food shortages during the Second World War, there 
were areas where people were poorly nourished and 
where bread was replaced by a non-cereal substitute. 
Dicke observed a recurrence of symptoms when bread 
was reintroduced after the war. Initially, CD was consid-
ered to be a childhood disease, and the frequency of the 
disease was estimated at about 1:4,000. After introducing 
new, more sensitive and more specific diagnostic tests, 
the recognisability of CD markedly increased. CD was 
more and more frequently diagnosed in adults. Further 
investigations revealed that the prevalence of CD is 
more often seen in patients with other autoimmune 
disorders such as autoimmune thyroid disease (AITD) 
[4–13], type 1 diabetes (T1DM) [14–16], and Addison’s 
disease [17–20]. The above-mentioned autoimmune 
	 I	 II	 IIIa	 IIIb	 IIIc
Figure 1. Extent of small intestinal mucosal changes according to the Marsh histological damage score; the figure shows spectrum of 
changes in mucosa of small intestine according to the Marsh classification and AGA. Histologically confirmed coeliac disease can be 
diagnosed in cases IIIa, IIIb, IIIc (villous atrophy at different degree) [34]
Rycina 1. Schemat przedstawiający zakres zmian błony śluzowej jelita cienkiego zgodnie z klasyfikacją Marsh; na rycinie przedstawiono 
zakres zmian w obrębie błony śluzowej jelita cienkiego zgodnie z klasyfikacją Marsh i kryteriami Amerykańskiego Towarzystwa 
Gastroenterologicznego. Histopatologicznie potwierdzoną celiakię można rozpoznać w przypadku zmian IIIa, IIIb, IIIc (zanik kosmków 
o różnym stopniu zaawansowania) [34]
Table I. Histologic grading in coeliac disease (Marsh) [34]
Tabela I. Klasyfikacja zmian histopatologicznych w celiakii 
(Marsh) [34]
Classification Description
Marsh 0 No changes in mucosal and villous architecture
Marsh I Normal mucosal and villous architecture
Increased numbers of intraepithelial 
lymphocytes
Marsh II Similar to Marsh I but with enlarged crypts 
(hyperplastic)
Marsh IIIa Partial villous atrophy
Marsh IIIb Subtotal villous atrophy
Marsh IIIc Total villous atrophy
Marsh IV Total villous atrophy and hypoplastic crypts
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diseases are part of the autoimmune polyglandular 
syndrome (APS). The coexistence of autoimmune 
diseases is probably connected to a common genetic 
predisposition.
Epidemiology
The prevalence of histologically confirmed CD in the 
general adult population in relation to screening re-
search from Europe (Italy, Holland, Germany, Great 
Britain, Iceland, Greece) and the United States has 
been estimated to be between 0.2 and 1.0% [21–27] 
(Tab. II). The data concerning CD in Poland regards 
mainly children and is based on classical symptoms 
of the disease, which is the reason for underdiagnosis 
(most research was performed in the 1980s and 1990s) 
[28–33]. There have been no screening studies evaluat-
ing the frequency of CD in adults in Poland.
Clinical manifestations and types  
of coeliac disease
Clinical symptoms of CD are characterised by a wide 
spectrum within the clinical picture. In younger patients 
(infants, young children), we often encounter the classi-
cal type of CD (chronic diarrhoea with hypoalbuminae-
mia, electrolyte abnormalities, abdominal pain) (Tab. III). 
Diarrhoea occurs significantly less often in older chil-
dren and adults. Complaints in these groups are often 
non-specific and less intensive (flatulence, temporary 
abdominal pain) or even absent [34]. These are so called 
atypical or silent types of the disease, which are difficult 
to diagnose. Symptoms may actually concern all systems 
within the human body (Tab. IV). With latent types of 
CD in patients with genetic predispositions (genotype 
HLA-DQ2 or DQ8), elevated IgA TTG and/or IgA EMA 
levels are to be found and minimal changes (increased 
intraepithelial lymphocytes of the intestine) or lack of 
any histological changes can be seen in tissue samples 
taken from the distal part of the duodenum. In order 
to describe the variability of CD, it is often compared to 
an iceberg. The tip above the water represents patients 
with classical symptoms, but the greater part, which 
is hidden, consists of asymptomatic patients or those 
with atypical symptoms [35, 36] (Fig. 2). There are no 
clearly marked borders between the different types of 
CD because of its numerous clinical symptoms, and its 
histological and immunological picture.
Table II. Prevalence of coeliac disease in different populations of healthy individuals
Tabela II. Badania przedstawiające częstość występowania choroby trzewnej w różnych populacjach zdrowych dorosłych osób
Study Population Size of the study group (n) Coeliac disease [%]
Rostami et al., 1999 [25] Holland 1,000 0.3%
Volta et al., 2001 [27] Italy 3,483 0.5%
Henker an et al., 2002 [22] Germany 4,313 0.2%
Fasano et al., 2003 [21] USA 2,848 1.0%#
Sanders an et al., 2003 [26] UK 1,200 1.0%
Roka et al., 2007 [24] Greece 2,230 0.2%
Johannsson et al., 2008 [23] Island 813 0.7%
Population — group of individuals on whom the study was performed; the study group — number of individuals who underwent serologic tests specific 
for coeliac disease; coeliac disease (%) — prevalence (%) of histologically confirmed coeliac disease in investigated population; #in Fasano’s study only 
serological tests were estimated (only 20% of individuals underwent endoscopy and histological evaluation)
Table III. Types of coeliac disease [1, 34]
Tabela III. Kliniczne postacie celiakii [1, 34]
Types of coeliac disease Clinical symptoms Serological evaluation: 
IgA EMA/IgA TTG
Histological evaluation 
of small bowel biopsy
Classic disease Symptoms of malabsorption + +
Atypical/poor symptomatic Minor gastrointestinal complaints or other symptoms + +
Asymptomatic/silent No symptoms + +
Latent/potential No symptoms + –
Serological evaluation: IgA EMA/IgA TTG (+) — elevated IgA endomysial antibodies and/or IgA tissue transglutaminase antibodies; histological 
evaluation of the small intestine (+) — at least partial villous atrophy — Marsh III; (–) — no villous atrophy in histological examination
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Diagnosis of coeliac disease
Diagnosis of CD is based on serological tests and his-
tological evaluation of a small bowel biopsy. In some 
doubtful situations, genetic tests can be performed 
(CD occurs in genetically predisposed individuals with 
HLA-DQ2 and/or DQ8). An approach to the diagnosis 
of CD is summarised in Figure 3.
Serological evaluations
All diagnostic tests should be performed during 
a gluten-rich diet. Nowadays, there are two tests of 
high sensitivity and specificity: IgA TTG and IgA EMA, 
which have equivalent diagnostic accuracy (Tab. V). IgA 
EMA was discovered by a Polish scientist, Professor 
Tadeusz Chorzelski, in 1983 [37]. Performing both of 
these tests improves sensitivity by almost 100%. Due to 
easier ambulatory procedures (ELISA, enzyme-linked 
immunosorbent assays), some scientists recommend us-
ing the IgA TTG test first (the IgA EMA test is frequently 
performed by a time-consuming indirect immunofluo-
rescence method). It is not advisable to use other serum 
antibodies’ assays (antigliadin, antireticuline). Some 
scientists recommend an evaluation of serum total anti 
IgA level, and when the result is negative, tests for IgG 
EMA and/or IgG TTG are recommended.
Histopathological examination
Patients positive with IgA EMA or IgA TTG should 
undergo endoscopy of the upper digestive tract with 
a small bowel biopsy (4–6 biopsies from the distal part 
of the duodenum). A wide spectrum of histological 
changes, ranging from increased intraepithelial lympho-
cytes to flat mucosal atrophy, contribute to histological 
changes in CD, which can be described using the Marsh 
classification (Tab. I) [34]. Diagnosis of CD is established 
in patients who have at least partial villous atrophy 
(Fig. 1). To avoid false diagnosis, the histological evalu-
ation should be performed in reference clinics.
Genetic evaluations
Antigen HLA-DQ2 is confirmed in 90–95%, and an-
tigen DQ8 in 5–10%, of patients with CD [38]. The 
presence of HLA-DQ2 and/or DQ8 is necessary for the 
development of symptoms of CD. However, genetic 
evaluations are very rarely performed, and they are 
restricted to situations in which other methods have 
failed. A negative result of genetic evaluation excludes 
a diagnosis of CD.
Table IV. Clinical symptoms of coeliac disease
Tabela IV. Objawy kliniczne celiakii
Organ abnormalities Symptoms
Digestive system Diarrhoea, constipation, distension, abdominal pain
Nervous system Ataxia, polyneuropathy, migraines, epilepsy
Reproductive disorders Women: delayed menarche, early menopause, higher rates of miscarriage, low birth weight
Men: hypogonadism, sexual dysfunction, low sperm quality
Haematological disorders Iron deficiency, vitamin B12 deficiency, folic acid deficiency, anaemia
Metabolic disorders Osteopenia, osteoporosis
Dermatologic disorders Dermatitis herpetiformis
Neoplasms Enteropathy-associated T-cell lymphoma-EATL, adenocarcinoma of small bowel, oropharynx and 
oesophagus
Others Elevated transaminase levels, prevalence to liver diseases (like primary sclerosing cholangitis, 
nonalcoholic fatty liver disease, liver cirrhosis and primary biliary cirrhosis), IgA deficiency, dental-enamel 
hypoplasia, hyposplenism, psychiatric disorders
Figure 2. Iceberg showing wide spectrum of clinical symptoms 
of coeliac disease (modified according to [35])
Rycina 2. Góra lodowa przedstawiająca spektrum objawów 
klinicznych celiakii (zmodyfikowano na podstawie [35])
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Coeliac disease and autoimmune diseases
Previous studies have shown that patients suffering 
from autoimmune diseases are more predisposed to CD 
compared to the general population. Examples of auto-
immune diseases are: T1DM, AITD, and Addison’s dise-
ase. The frequency of autoimmune diseases associated 
with CD is depicted in Table VI. Simultaneously, judg-
ing from other studies of patients with CD, it may be 
stated that the frequency of other autoimmune diseases 
in patients with CD is also above normal compared to 
a healthy population. Therefore, in all cases regarding 
patients with autoimmune disease and suspected of suf-
fering from CD, a proper diagnostic evaluation should 
be performed. This often leads to the diagnosis of pa-
tients with CD of non-typical symptoms. The diagnosis 
of CD and initiation of the correct therapy (gluten-free 
diet) can prevent patients from suffering from many 
disorders. Additionally, effective therapy can influence 
the course and treatment of other autoimmune diseases 
Figure 3. The diagnostic approach to coeliac disease (adapted from [70], up to date 19.2); *moderate or high probability: family history, 
iron-deficiency anaemia of unknown origin, diarrhoea, failure to thrive in children, type 1 diabetes; IgA TTG: IgA tissue transglutaminase 
antibodies; IgA EMA: IgA antiendomysial antibodies; antibodies: IgA EMA and/or IgA TTG; Consider 1: repeat IgA TTG, repeat biopsy 
in reference clinic, multiply biopsy, histological evaluation by another pathologist, review adherence to gluten free diet; Consider 2: total 
IgA measurement, perform genetic tests (HLA DQ2, -DQ8), consider other than coeliac disease causes of villous atrophy (cow milk 
or other proteins intolerance, giardiasis, eosinophilic gastroenteritis, duodenitis, intestinal ischaemia, intestinal lymphoma, Crohn’s 
disease, severe malnutrition)
Rycina 3. Schemat diagnostyczny celiakii (opracowano na podstawie [70], uptodate 19.2); *ryzyko średnie i duże: obciążający wywiad 
rodzinny w kierunku celiakii, niedokrwistość z niedoboru żelaza o niejasnej etiologii, biegunka tłuszczowa, opóźnione wzrastanie 
u dzieci, cukrzyca typu 1; IgA TTG — przeciwciała przeciwko tkankowej transglutaminazie w klasie IgA; IgA EMA — przeciwciała 
przeciwendomyzjalne w klasie IgA; przeciwciała: IgA EMA i/lub IgA TTG: Rozważ 1: powtórzenie IgA TTG, powtórzenie biopsji 
w referencyjnym ośrodku, wykonanie większej liczby wycinków, ocena wycinków przez drugiego histopatologa, sprawdzenie czy pacjent 
przyjmował regularną dietę; Rozważ 2: pomiar stężenie całkowitego IgA, wykonanie badania genetycznego HLA DQ2, -DQ8, rozważenie 
innej przyczyny atrofii kosmków (nietolerancja mleka krowiego oraz innych białek, giardioza, eozynofilowe zapalenie błony śluzowej 
żołądka i jelit, zapalenie błony śluzowej dwunastnicy, niedokrwienie jelit, chłoniak jelita cienkiego, choroba Leśniowskiego-Crohna, 
ciężkie niedożywienie)
Table V. Sensitivity and specificity of serological tests in diagnostics of coeliac disease (adapted from [34])
Tabela V. Czułość i specyficzność badań serologicznych w diagnostyce celakii (zmodyfikowano na podstawie [34])
Antibodies Sensitivity 95% Cl Specificity 95% Cl
IgA TTG 95.1% 91.8–98.1 98.3% 97.1–99.6%
IgA EMA 90.2% 86.3–92.5% 99.6% 98.4–99.9%
IgA TTG — IgA tissue transglutaminase antibodies; IgA EMA — IgA endomysial antibodies; CI — confidence interval
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which accompany CD (for example lowering doses of 
levothyroxine in patients with hypothyroidism, and 
lowering doses of hydrocortisone in patients with pri-
mary adrenal insufficiency).
Pathogenesis of the coincidence of coeliac disease 
and other autoimmune diseases
CD can appear separately or be a part of APS. Ac-
cording to the definition, APS is a group of diseases 
of autoimmune origin characterised by hypofunction 
of a couple of endocrine glands [39, 40]. A common 
genetic origin is the reason that a patient with one 
autoimmune disease is more predisposed to other 
autoimmune diseases. The occurrence of the symp-
toms of these diseases is usually not synchronised 
in time. A patient diagnosed with one autoimmune 
disease often shows a positive result with antibod-
ies characterised for another autoimmune disease, 
although without yet displaying clinical symptoms or 
organ failure. This can be called potential or silent APS 
[41]. An example of this kind of syndrome is the state-
ment of presence of antibodies specific for CD (e.g. 
IgA TTG), without any specific histological changes 
in a patient with another autoimmune disorder (e.g. 
GD). More detailed research, for example by using 
an electron microscope, can confirm microvillous 
atrophy in some of these patients [42]. It is confirmed 
that some patients will develop the full histological 
features of CD in the future.
We can define different types of APS, which depends 
on the associated conditions of the diseases. Enthusiasts 
of narrow classification classify APS into two groups 
[43], while others classify APS into three [40] or even 
four groups [44] (Tab. VII).
APS types are distinguished according to different 
modes of inheritance. APS 1 is rare, usually appears 
in childhood, is monogenic, and is connected to mu-
tations in an autoimmune-suppressor gene (AIRE, 
autoimmune regulator). It is defined by the presence 
of hypoparathyroidism, adrenal insufficiency and 
chronic mucocutaneous candidiasis. Other APS types 
are multigenic disorders and occur in adulthood [40]. 
A strong association with the HLA complex, mainly 
DR3-DQ2 and DR4-DQ8, could be an explanation for 
the coexistence of CD and other autoimmune disorders 
[45–49]. It was stated in a course of self study that the 
frequency of CD was significantly higher (p < 0.05) in 
the subgroup of patients with Graves’ disease carrying 
HLA DRB1*03 alleles [50].
Table VII. Classification of autoimmune polyendocrine syndromes (APS)
Tabela VII. Podział autoimmunologicznych zespołów niedoczynności wielogruczołowej (APS)
Authors APS-1 APS-2 APS-3 APS-4
Neufeld et al.,  
1980 [44]
AD, candidiasis#, 
hypoparathyroidism‡  
(at least two present)
AD (always present) 
plus AITD  
and/or T1DM
AITD plus another AID  
(except from AD and 
hypoparathyroidism)
Combination of AID 
not mentioned in the 
previous groups
Eisenbarth et al.,  
2004 [43]
AD, candidiasis#, 
hypoparathyroidism‡  
(at least two present)
AD, AITD, T1DM  
(at least two present)
Lewiński 2005, [44] AD, candidiasis#, 
hypoparathyroidism‡  
(at least two present)
AD (always present) 
plus: AITD†, AITD 
and T1DM* T1DM
AITD, ABD, T1DM, vitiligo:  
(at least two present)
APS-3A: AITD and T1DM
APS-3B: AITD and ABD
APS-3C: AITD plus other organ- 
-specific AID (e.g. coeliac disease)
The table shows classification of APS and components of each type according to above-mentioned authors; #candidiasis — chronic candidiasis of 
mucosa and skin; ‡hypoparathyroidism — hypoparathyroiditis of autoimmune origin; †Schmidt syndrome; *Carpenter syndrome; AD — Addison’s 
disease; AITD — autoimmune thyroid disease; T1DM — type 1 diabetes; AID — autoimmune disease; ABD — Addison-Biermer disease
Table VI. Prevalence of coeliac disease in patients with other 
autoimmune disorders and healthy volunteers (modified 
according to [4–27])
Tabela VI. Częstość występowania celiakii u pacjentów 
z innymi chorobami autoimmunologicznymi i u zdrowych 
ochotników (zmodyfikowano na postawie [4–27])
Study group Prevalence of coeliac 
disease (%)
Hashimoto’s thyroiditis 0–9.1
Graves’ disease 0–5.5
Addison’s disease 5.4–12.2
Type 1 diabetes mellitus in children 3.0–8.0
Type 1 diabetes mellitus in adults 2.0–5.0
Autoimmune hepatitis 2.9–6.4
Healthy volunteers 0.2–1.0
246
Coeliac disease and other autoimmune disorders Piotr Miśkiewicz et al.
SZ
K
O
LE
N
IE
 
PO
D
Y
PL
O
M
O
W
E
Autoimmune disorders  
associated with coeliac disease
Type 1 diabetes
The majority of studies released so far concern the pres-
ence of CD with another autoimmune disorder: T1DM.
Prevalence
Research was first performed by paediatricians over 
30 years ago. At that time, only the classical form of 
CD was diagnosed. Diagnosis was based on symptoms 
such as steatorrhoea, malnutrition, and growth and 
development disorders in children. The frequency 
of CD in patients with T1DM was established at the 
level of 1.0–1.5% [51] which was significantly under-
estimated (as it later turned out after the introduction 
of serological assays as a diagnostic tool). In recent 
investigations, where specific diagnostic tests are 
used, the frequency of histologically confirmed CD in 
patients with T1DM is estimated at the level of 2–5% 
in adults and 3–9% in children [14–16]. According to 
some researchers, the following criteria are connected 
to a higher prevalence of CD in patients with T1DM: 
young age [53], female gender [52], younger age at 
diagnosis of T1DM [53].
Clinical manifestations
Among the clinical symptoms suggesting association 
of CD with T1DM, apart from typical symptoms, there 
may be episodes of hypoglycaemia caused by malab-
sorption. A gluten-free diet for patients with TD1 and 
CD can reduce these episodes in some cases. There-
fore, changing the diet of these patients to one which 
is gluten-free usually increases insulin requirements, 
thus doses of insulin must be changed. We have to 
remember that diarrhoea, a clinical feature of CD, 
can also occur in association with bowel neuropathy 
as observed in T1DM.
Recommendations for diagnostic evaluation
The Polish Diabetes Association, in its guidelines 
from 2011, recommends CD screening in children and 
young people with T1DM once a year [54]. The Ameri-
can Diabetes Association (ADA), in its guidelines 
from 2011, recommends CD diagnosis when there is 
an appearance of clinical symptoms, periodic screen-
ing studies of asymptomatic patients with T1DM 
and diagnostic tests in all children with recently di-
agnosed T1DM [55]. However, the guidelines of the 
National Institute of Health (NIH) from 2004 [56] and 
the American Gastroenterological Association (AGA) 
[34, 57] from 2006 recommend a diagnostic approach 
to CD in patients with T1DM when the symptoms of 
CD are present.
Autoimmune thyroid diseases
Studies of the presence of CD among patients with 
autoimmune thyroid diseases (AITD) have concerned 
mainly individuals with Hashimoto’s thyroiditis (HT). 
Because of the different genetic factors of HT and GD, 
these two diseases cannot be analysed as one group [58].
Prevalence
There were two studies performed concerning the fre-
quency of CD in patients with GD [4, 5]. In other investiga-
tions patients with GD have constituted only a small sub-
group of patients with AITD (from 18 to 100 individuals). 
In these studies, elevated antibody levels, typical of CD, 
were present in approximately 3.7% of patients (ranging 
from 0 to 7.2%) and CD was finally diagnosed (histological 
evaluation) in approximately 2.5% (ranging from 0% to 
5.5%) [4–10, 13]. In self studies performed on 238 patients 
with GD, an elevated level of antibodies specific to CD 
(IgA TTG or IgA EMA) was confirmed in 5.9% of patients 
and a histological diagnosis of CD was diagnosed in 3.4% 
of patients [59]. In studies estimating the prevalence of 
CD in patients with HT, an elevated level of autoantibod-
ies specific to CD was present in approximately 3.9% of 
patients (ranging from 0% to 9.1%) [6, 7, 9–13]. Diagnosis 
of CD was established in approximately 3.1% (ranging 
from 0% to 9.1%) of patients. In all studies carried out so 
far, no predisposition to CD in AIDT patients concerned 
with age or gender has been observed. In a study in2010, 
the frequency of autoimmune diseases in a group of 2,791 
patients with GD and 491 patients with HT was 0.9% and 
1.0% respectively [60]. The coexistence of CD and AITD 
was assessed only according to a questionnaire, which was 
probably the reason for the underestimation.
Clinical manifestations
Many patients with HT and GD suffering from CD have 
atypical CD. Some symptoms typical of CD such as diar-
rhoea and weight loss can be incorrectly interpreted as 
symptoms of hyperthyroidism in GD, which leads to 
delayed diagnosis. One of the symptoms which indicate 
the possibility of a coexistence of CD and AITD (HT or 
GD after radical treatment) is related to situations con-
nected to hypothyroidism. In these cases, often a higher 
dose of levothyroxine (up to 200 ug per day and more) 
is required and a gluten-free diet leads, after some time, 
to a reduction in doses of hormonal substitution.
Recommendations for diagnostic evaluation
Currently, there are no indications from the Polish En-
docrine Society concerning establishing a diagnosis of 
CD in patients with HT and GD. The NIH (2004) [56] 
and the AGA (2006) [4, 57] recommend a diagnostic 
approach towards CD in patients with AIDT in case of 
the appearance of CD symptoms.
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Other autoimmune disorders
Research projects concerning the presence of CD 
among other autoimmune disorders are numerous and 
are usually performed on small groups of patients. In 
a couple of published studies regarding patients with 
primary adrenal insufficiency, in various groups of 17 
to 109 patients, a diagnosis of CD was established in 
5.4% to 12.2% of patients [17, 20]. Authors focus on the 
possibility of similar symptoms in both diseases, which 
leads to a postponement in establishing a diagnosis 
of CD (losing weight, abdominal pain, diarrhoea). In 
numerous case reports, there is some data about the 
coincidence of CD and primary hypoparathyroidism of 
autoimmune origin [61–63]. It is important to remember 
this, especially in patients with deep hypocalcaemia ac-
companied by the symptoms of tetany. As opposed to 
this situation in which parathormone serum concentra-
tion is low, in patients with hypocalcaemia, connected 
to malabsorption in CD, an elevation of serum PTH 
concentration may occur.
There is some data regarding CD and its coexist-
ence with lymphocytic hypophysitis [64], alopecia 
areata [65–67], and pernicious anaemia. It is essential to 
remember that megaloblastic anaemia of B12 vitamin 
deficiency can be caused by poor absorption in patients 
with CD and the presence of autoantibodies in patients 
with pernicious anaemia as well. As a result, when CD is 
associated with pernicious anaemia there are indications 
for a diagnostic evaluation of the presence of autoim-
mune features (autoantibodies to intrinsic factor).
Studies estimating the prevalence of autoimmune 
diseases in patients with CD relate to a much larger 
group of patients. Among these studies, the vast major-
ity concern AIDT and Addison’s disease. In a study of 
14,021 patients with CD compared to a control group of 
68,068, for the first time a significant increase in AITD 
was diagnosed (HR = 2.9; 95% Cl = 2.0–4.2; p < 0.001) 
[68]. In another study performed by the same authors 
on the same group of patients with CD, a higher preva-
lence of Addison’s disease was observed compared to 
a healthy control group (HR = 11.4; 95% Cl = 4.4–29.6; 
p < 0.001) [69].
Recommendations concerning  
the diagnostic approach to coeliac disease 
in patients with autoimmune disorders
Recommendations concerning the diagnostic approach 
to CD in patients with autoimmune disorders are am-
biguous and differ according to which autoimmune 
disease is present, and the Society summarising the data. 
At present, the most up-to-date and strict guidelines are 
those formulated by the ADA. There are no guidelines 
from Polish Societies, apart from the Polish Diabetes 
Society. This probably stems from a lack of data con-
cerning the prevalence of CD in the Polish population 
of patients with other than T1DM autoimmune disor-
ders. According to the present guidelines of the NIH 
(2004) [56] (Tab. VIII) [34, 57], patients with autoimmune 
disorders should undergo a diagnostic approach to CD 
in the presence of any symptoms suggesting CD. With 
relevance to atypical or even silent course of CD types, 
it may lead to lower detectability.
It would require further clinical studies on larger 
groups of patients with autoimmune disorders to 
estimate the prevalence of CD in these patients, and 
potential modification of the guidelines.
Remember!
CD is one of the most frequent diseases of autoim-
mune origin, diagnosed, on average, in one out of 100 
Table VIII. Recommendations concerning the diagnostic approach to coeliac disease in adult patients based on NIH 
recommendations [56]
Tabela VIII. Zalecenia dotyczące diagnostyki celiakii u dorosłych oparte na zaleceniach NIH [56]
Diagnostic approach to coeliac disease Diagnostic approach to coeliac 
disease in symptomatic patients
Diagnostic approach to coeliac disease not 
recommended
Malabsorption, isolated iron deficiency Family history of coeliac disease General population
Infertility Autoimmune thyroid disease Short history of symptoms from digestive system
Osteoporosis Sjögren’s syndrome Type 1 diabetes**
Ataxia and polyneuropathy Type 1 diabetes*
Arthritis of unknown origin Addison’s disease
Chronic liver disease of unknown origin Symptoms from digestive system
Dermatitis herpetiformis
Irritable bowel syndrome
*With symptoms of coeliac disease, **without symptoms of coeliac disease
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individuals. The results of studies indicate that there is 
an increased prevalence of CD in patients with other 
diseases of autoimmune origin. The coexistence of CD 
with other autoimmune diseases is probably connected 
to a common genetic predisposition. 
The majority of adult patients suffer from atypical or 
silent types of the disease, something which postpones 
proper diagnosis. CD, if undiagnosed or untreated, can 
lead to many medical disorders. 
The diagnostic approach to CD is based on serologi-
cal evaluation (specific antibodies — IgA TTG and IgA 
EMA of equivalent diagnostic accuracy). In many cases, 
an evaluation of IgA TTG can be routinely considered 
as a screening test. A patient with a positive serological 
evaluation should undergo endoscopy with a biopsy of 
the descending part of the duodenum. 
Introducing a strict gluten-free diet in patients with 
CD can decrease the risk of many of the medical disor-
ders mentioned above. 
In patients with endocrinopathies of autoimmune 
origin, in the diagnostic process of many symptoms 
and diseases (for example iron deficiency, non-specific 
abdominal symptoms, abnormal serum transaminases, 
infertility), the coexistence of CD should always be 
considered.
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